Patient Portal

Gerald L. Andriole Jr., MD

Robert Killian Royce Distinguished Professor
Professor, Surgery
Chief, Division of Urologic Surgery

Specialty Areas

Urologic Surgery
Urologic Oncology
Prostate Cancer

Board Certifications

Urology

Hospital Affiliations

Progress West Hospital
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St. Louis Children's Hospital
VA Medical Center - St. Louis

Areas of Clinical Interest

Prostate cancer, benign prostate hyperplasia, prostatectomy, penile cancer, bladder cancer, PSA, prostate specific antigen, BPH, kidney tumors, kidney cancer

  • Location(s)
  • Education
  • Publication & Research
  • In the News
  • Financial Disclosures
  • Videos

Location(s)

Location(s)

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129

Barnes-Jewish West County Hospital
Medical Building One

1040 N. Mason Road
Creve Coeur, MO 63141

Suite: Suite 122,
Barnes-Jewish West County Hospital
Office Phone: 314-362-8200
Fax: 314-361-2203

Center for Advanced Medicine
Urologic Surgery Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 11
Office Phone: 314-362-8200
Fax: 314-361-2203

Alton Memorial Hospital - Medical Office Building A

2 Memorial Drive
Alton, IL 62002

Suite: 205
Office Phone: 618-463-7174

Education

Education

Fellowship: National Cancer Institute 1985
Residency: Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 1983
Residency: Surgery, Strong Memorial Hospital, University of Rochester, Rochester, New York 1980
Medical School: Jefferson Medical College, Philadelphia 1978
B.S.Accelerated Med.: Pennsylvania State University, State College, PA 1976

Publication & Research

Publication & Research

Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Pinsky PF, Black A, Daugherty SE, Hoover R, Parnes H, Smith ZL, Eggener S, Andriole GL, Berndt SI
Cancer. 2019 May 8; doi: 10.1002/cncr.32176.

PMID:
    31067347
    [PubMed - as supplied by publisher]
Related citations


A longitudinal analysis of urologic chronic pelvic pain syndrome flares in the mapp research network.
Sutcliffe S, Gallop R, Lai HH, Andriole GL, Bradley CS, Chelimsky G, Chelimsky T, Clemens JQ, Colditz GA, Erickson B, Griffith JW, Kim J, Krieger JN, Labus J, Naliboff BD, Rodriguez LV, Sutherland SE, Taple BJ, Landis JR, MAPP Research Network.
BJU Int. 2019 Apr 23; doi: 10.1111/bju.14783.

PMID:
    31012513
    [PubMed - as supplied by publisher]
Related citations


Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
Freitas D, Andriole GL, Freedland SJ, Neto BS, Moreira DM
Urology. 2019 Mar 23; pii: S0090-4295(19)30312-7. doi: 10.1016/j.urology.2019.02.034.

PMID:
    30914334
    [PubMed - as supplied by publisher]
Related citations


The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors.
Pickersgill NA, Vetter JM, Raval NS, Andriole GL, Shetty AS, Ippolito JE, Kim EH
Urology. 2019 May; 12768-73. doi: 10.1016/j.urology.2019.01.035.

PMID:
    30807773
    [PubMed - in process]
Related citations


The association of atrophy in baseline prostate biopsy and lower prostate cancer grade in radical prostatectomy specimens.
Freitas DMO, Andriole GL, Castro-Santamaria R, Freedland SJ, Moreira DM
Scand J Urol. 2018 Oct - Dec; 52(5-6)328-332. doi: 10.1080/21681805.2018.1551244.

PMID:
    30762450
    [PubMed - in process]
Related citations


Management of Symptom Flares and Patient-reported Flare Triggers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)-Findings From One Site of the MAPP Research Network.
Lai HH, Vetter J, Song J, Andriole GL, Colditz GA, Sutcliffe S
Urology. 2019 Apr; 12624-33. doi: 10.1016/j.urology.2019.01.012.

PMID:
    30682464
    [PubMed - in process]
Related citations


A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.
Fischer-Valuck BW, Michalski JM, Contreras JA, Brenneman R, Christodouleas JP, Abraham CD, Kim EH, Arora VK, Bullock AD, Carmona R, Figenshau RS, Grubb R 3rd, Knoche EM, Pachynski RK, Picus J, Roth BJ, Sargos P, Andriole GL, Gay HA, Baumann BC
Clin Transl Radiat Oncol. 2019 Feb; 1538-41. doi: 10.1016/j.ctro.2018.12.001.

PMID:
    30656221
    [PubMed]
Related citations


Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA, Profile Study., Australian Prostate Cancer BioResource (APCB)., IMPACT Study., Canary PASS Investigators., Breast and Prostate Cancer Cohort Consortium (BPC3)., PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium., Cancer of the Prostate in Sweden (CAPS)., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS)., Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.
Nat Genet. 2019 Feb; 51(2)363. doi: 10.1038/s41588-018-0330-6.

PMID:
    30622367
    [PubMed]
Related citations


Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy.
Bhat NR, Vetter JM, Andriole GL, Shetty AS, Ippolito JE, Kim EH
Urology. 2019 Apr; 126152-157. doi: 10.1016/j.urology.2018.12.010.

PMID:
    30580005
    [PubMed - in process]
Related citations


Editorial Comment.
Sivaraman A, Kim EH, Andriole GL
J Urol. 2019 Jan; 201(1)112. doi: 10.1097/01.ju.0000550164.56925.06.

PMID:
    30577401
    [PubMed - indexed for MEDLINE]
Related citations


Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms.
Treviño-Villarreal JH, Reynolds JS, Bartelt A, Langston PK, MacArthur MR, Arduini A, Tosti V, Veronese N, Bertozzi B, Brace LE, Mejia P, Trocha K, Kajitani GS, Longchamp A, Harputlugil E, Gathungu R, Bird SS, Bullock AD, Figenshau RS, Andriole GL, Thompson A, Heeren J, Ozaki CK, Kristal BS, Fontana L, Mitchell JR
JCI Insight. 2018 Nov 2; 3(21)pii: 99470. doi: 10.1172/jci.insight.99470.

PMID:
    30385734
    [PubMed - in process]
Related citations


Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.
Pickersgill NA, Vetter JM, Andriole GL, Shetty AS, Fowler KJ, Mintz AJ, Siegel CL, Kim EH
Eur Urol Focus. 2018 Oct 13; pii: S2405-4569(18)30301-8. doi: 10.1016/j.euf.2018.10.008.

PMID:
    30327280
    [PubMed - as supplied by publisher]
Related citations


Prostate Cancer Review.
Kim EH, Andriole GL
Mo Med. 2018 Mar-Apr; 115(2)131.

PMID:
    30228703
    [PubMed - in process]
Related citations


Nocturia and associated mortality: observational data from the REDUCE trial.
Bliwise DL, Howard LE, Moreira DM, Andriole GL, Hopp ML, Freedland SJ
Prostate Cancer Prostatic Dis. 2019 Mar; 22(1)77-83. doi: 10.1038/s41391-018-0090-5.

PMID:
    30214036
    [PubMed - indexed for MEDLINE]
Related citations


The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA, Schuster DM, Siegel BA, LOCATE Study Group.
J Urol. 2019 Feb; 201(2)322-331. doi: 10.1016/j.juro.2018.08.050.

PMID:
    30179618
    [PubMed - indexed for MEDLINE]
Related citations


Improved Detection of Clinically Significant Prostate Cancer With Software-assisted Systematic Biopsy Using MR/US Fusion in Patients With Negative Prostate MRI.
Meng Y, Vetter JM, Parker AA, Arett CT, Andriole GL, Shetty AS, Fowler KJ, Kim EH
Urology. 2018 Oct; 120162-166. doi: 10.1016/j.urology.2018.06.020.

PMID:
    29958965
    [PubMed - indexed for MEDLINE]
Related citations


Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion.
Monda SM, Vetter JM, Andriole GL, Fowler KJ, Shetty AS, Weese JR, Kim EH
Urology. 2018 Sep; 119115-120. doi: 10.1016/j.urology.2018.06.011.

PMID:
    29940232
    [PubMed - indexed for MEDLINE]
Related citations


The Association of Previous Prostate Biopsy Related Complications and the Type of Complication with Patient Compliance with Rebiopsy Scheme.
Schwarzman LS, Abern MR, Garvey DF, Andriole GL, Freedland SJ, Moreira DM
J Urol. 2018 Nov; 200(5)1062-1067. doi: 10.1016/j.juro.2018.06.018.

PMID:
    29906435
    [PubMed - in process]
Related citations


Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA, Profile Study., Australian Prostate Cancer BioResource (APCB)., IMPACT Study., Canary PASS Investigators., Breast and Prostate Cancer Cohort Consortium (BPC3)., PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium., Cancer of the Prostate in Sweden (CAPS)., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS)., Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.
Nat Genet. 2018 Jul; 50(7)928-936. doi: 10.1038/s41588-018-0142-8.

PMID:
    29892016
    [PubMed - indexed for MEDLINE]
Related citations


Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy.
Kuang AG, Nickel JC, Andriole GL, Castro-Santamaria R, Freedland SJ, Moreira DM
BJU Int. 2019 Jan; 123(1)91-97. doi: 10.1111/bju.14428.

PMID:
    29873889
    [PubMed - in process]
Related citations

In the News

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Stratify Genomics

Royalties:

Equity: Yes

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2019

Videos

Videos